Outcomes of right sleeve lower lobectomy vs. lower bilobectomy for lung malignancies.

Bilobectomy Outcomes. lung cancer Sleeve lobectomy Survival

Journal

Surgical oncology
ISSN: 1879-3320
Titre abrégé: Surg Oncol
Pays: Netherlands
ID NLM: 9208188

Informations de publication

Date de publication:
29 Jun 2024
Historique:
received: 05 02 2024
revised: 09 06 2024
accepted: 28 06 2024
medline: 19 7 2024
pubmed: 19 7 2024
entrez: 18 7 2024
Statut: aheadofprint

Résumé

Lower bilobectomy (LBL) leaves a residual pleural space potentially associated with adverse postoperative outcomes. In selected patients, right sleeve lower lobectomy (RSLL) with anastomosis between the middle lobe bronchus and intermediate bronchus is feasible. The outcomes of RSLL and LBL have not been compared. The aim of this study was to compare post-operative and long-term outcomes of RSLL and LBL in patients with lung cancer. We retrospectively included patients managed by RSLL or LBL at our referral chest-surgery institution between 2001 and 2019. Post-operative complications and mortality were compared. Kaplan-Meier curves were plotted to compare overall and disease-free survival rates. We identified 23 patients with RSLL and 96 with LBL. Postoperative mortality was 9 % after RSLL and 5 % after LBL (p = 0.41). Bronchial fistula developed in 3 (13 %) RSLL patients and 6 (6 %) LBL patients (p = 0.23). Pleural space complications were significantly less common after RSLL (4/23 [17 %] vs. 45/96 [47 %], p = 0.03). Long-term vital capacity was significantly higher in the RSLL group (91 % vs. 64 %, p < 0.01). Five-year survival did not differ significantly between groups (84 % vs. 72 %, p = 0.09). RSLL was associated with similar postoperative mortality and long-term survival compared to LBL. However, pleural space complications were less common and lung function was better after RSLL than after LBL. When feasible, RSLL may deserve preference over LBL in patients with lung cancer managed at highly experienced centres.

Identifiants

pubmed: 39024682
pii: S0960-7404(24)00068-9
doi: 10.1016/j.suronc.2024.102100
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102100

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The other authors have no disclosure to declare for this work.

Auteurs

Justin Issard (J)

Department of Thoracic Surgery and Heart-lung Transplantation, Université Paris-Saclay, Marie Lannelongue Hospital, International Center for Thoracic Cancers, Le Plessis Robinson, France.

Geoffrey Brioude (G)

Department of Thoracic Surgery, CHU Hôpital Nord, Marseille, France.

Delphine Mitilian (D)

Department of Thoracic Surgery and Heart-lung Transplantation, Université Paris-Saclay, Marie Lannelongue Hospital, International Center for Thoracic Cancers, Le Plessis Robinson, France.

Dominique Fabre (D)

Department of Thoracic Surgery and Heart-lung Transplantation, Université Paris-Saclay, Marie Lannelongue Hospital, International Center for Thoracic Cancers, Le Plessis Robinson, France.

Vincent Thomas de Montpreville (V)

Department of Pathology, Marie Lannelongue Hospital, International Center for Thoracic Cancers, Le Plessis Robinson, France.

Amir Hanna (A)

Department of Thoracic Surgery and Heart-lung Transplantation, Université Paris-Saclay, Marie Lannelongue Hospital, International Center for Thoracic Cancers, Le Plessis Robinson, France.

Caroline Caramella (C)

Department of Radiology, Marie Lannelongue Hospital, International Center for Thoracic Cancers, Le Plessis Robinson, France.

Cécile Lepechoux (C)

Department of Radiation Therapy, Gustave Roussy, Université Paris-Saclay, International Center for Thoracic Cancers, Villejuif, France.

Benjamin Besse (B)

Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, International Center for Thoracic Cancers, Villejuif, France.

Olaf Mercier (O)

Department of Thoracic Surgery and Heart-lung Transplantation, Université Paris-Saclay, Marie Lannelongue Hospital, International Center for Thoracic Cancers, Le Plessis Robinson, France. Electronic address: olaf.mercier@universite-paris-saclay.fr.

Elie Fadel (E)

Department of Thoracic Surgery and Heart-lung Transplantation, Université Paris-Saclay, Marie Lannelongue Hospital, International Center for Thoracic Cancers, Le Plessis Robinson, France.

Classifications MeSH